<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0873-2159</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Pneumologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Pneumol]]></abbrev-journal-title>
<issn>0873-2159</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Pneumologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0873-21592007000200009</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Massas pulmonares bilaterais: Mesma etiologia?]]></article-title>
<article-title xml:lang="en"><![CDATA[Bilateral lung masses: The same aetiology?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Damas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Saleiro]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hespanhol]]></surname>
<given-names><![CDATA[VP]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital de São João Serviço de Pneumologia ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidade do Porto Faculdade de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2007</year>
</pub-date>
<volume>13</volume>
<numero>2</numero>
<fpage>287</fpage>
<lpage>291</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0873-21592007000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0873-21592007000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0873-21592007000200009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Os autores descrevem o caso de uma mulher de 50 anos, fumadora. Assintomática até Setembro de 2003, altura em que refere o aparecimento de tosse seca, cansaço e perda de peso. Na radiografia do tórax eram evidentes duas massas, uma no lobo superior direito e outra no lobo lingular. A doente foi submetida a biópsia aspirativa transtorácica e a citologia obtida foi compatível com carcinoma de pulmão do tipo pequenas células. No estadiamento da doença foram identificadas lesões hepáticas secundárias, motivo porque a doença foi considerada como disseminada, dada a existência de lesões hepáticas e pulmonares contra-laterais. Foi, nesta fase, iniciada quimioterapia com carboplatinum e etoposídeo. Seis meses mais tarde, a lesão direita inha diminuído, mas a lesão esquerda apresentava aumento das suas dimensões. A biópsia desta lesão mostrou uma citologia compatível com adenocarcinoma do pulmão, motivo porque inicia novo ciclo de quimioterapia com vinorelbina e gencitabina. Aos quatro ciclos e por não se evidenciar nenhuma resposta ao tratamento, foi realizada radioterapia da lesão esquerda. Durante este período (28 meses) mantém-se assintomática, mantendo a sua actividade diária habitual. De acordo com o momento do diagnóstico as neoplasias do pulmão podem ser consideradas síncronas ou metácronas. Estas últimas são mais frequentes, representando cerca de 50-70% dos casos, sendo o padrão histológico mais frequente o adenocarcinoma. No caso apresentado, a situação parecia ser uma doença disseminada, o que afastou a hipótese de tumores síncronos. Apesar de a doença se apresentar num estádio avançado aquando do diagnóstico e do mau prognóstico associado, a evolução dos dois tipos de tumor não pareceu comprometer a actividade diária da doente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The authors describe the case of a 50 year old woman, smoker, healthy until September 2003 when she presented persistent dry cough, fatigue and weight loss. Chest x-ray showed two lung masses, one in the superior right lobe and the other in the lingula lobe of the left lung. The patient underwent TFNA (transthoracic fine needle aspiration) and the cytological result was compatible with small cell lung cancer. Staging procedures identified hepatic lesions, probably secondary. Presence of hepatic metastasis and contralateral lung lesions defined the stage of the disease as disseminate. Chemotherapy with carboplatin and etoposide was started. Six months later the right lesion had decreased but the left lesion had increased. TFNA of this lesion revealed adenocarcinoma. A new treatment was started with vinorelbine and gemcitabine. After four cycles of chemotherapy without any response patient underwent radiotherapy of the left lesion. After 28 months of follow up the patient was asymptomatic and able to manage her normal daily routine. Multiple lung cancers can be considered as synchronous or metachronous, depending on the time of diagnosis. Metachronous lesions are the most frequent (50-70% of all cases) and adeno- carcinoma the more frequent histological pattern. In this case the disease was at a disseminate stage, which did not suggest a synchronous lung tumour. While the disease was at an advanced stage with poor prognosis at diagnosis, the evolution of the two different lung tumours did not seem to compromise patient’s daily routine.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Tumor primitivo do pulmão]]></kwd>
<kwd lng="pt"><![CDATA[tumores síncronos do pulmão]]></kwd>
<kwd lng="pt"><![CDATA[tumores metácronos do pulmão]]></kwd>
<kwd lng="en"><![CDATA[Primitive lung tumor]]></kwd>
<kwd lng="en"><![CDATA[synchronous tumor]]></kwd>
<kwd lng="en"><![CDATA[metachronous lung tumour]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p><b>Massas pulmonares bilaterais. Mesma etiologia?</b></p>     <p><b>Bilateral lung masses: The same aetiology?</b></p>      <p>&nbsp;</p>      <p><b>C Damas</b><sup><a href="#1">1</a><a name="top1"></a></sup></p>     <p><b>S Saleiro</b><sup><a href="#2">2</a><a name="top2"></a></sup></p>     <p><b>VP Hespanhol</b><sup><a href="#2">2</a><a name="top2"></a>,<a href="#3">3</a><a name="top3"></a></sup></p>      <p>&nbsp;</p>      <p align="center"><b>Resumo</b></p>     <p align="justify">Os autores descrevem o caso de uma mulher de 50 anos, fumadora.    Assintom&aacute;tica at&eacute; Setembro de 2003, altura em que refere o aparecimento    de tosse seca, cansa&ccedil;o e perda de peso. Na radiografia do t&oacute;rax    eram evidentes duas massas, uma no lobo superior direito e outra no lobo lingular.</p>     <p align="justify">A doente foi submetida a bi&oacute;psia aspirativa transtor&aacute;cica    e a citologia obtida foi compat&iacute;vel com carcinoma de pulm&atilde;o do    tipo pequenas c&eacute;lulas. No estadiamento da doen&ccedil;a foram identificadas    les&otilde;es hep&aacute;ticas secund&aacute;rias, motivo porque a doen&ccedil;a    foi considerada como disseminada, dada a exist&ecirc;ncia de les&otilde;es hep&aacute;ticas    e pulmonares contra-laterais. Foi, nesta fase, iniciada quimioterapia com carboplatinum    e etopos&iacute;deo. Seis meses mais tarde, a les&atilde;o direita inha diminu&iacute;do,    mas a les&atilde;o esquerda apresentava aumento das suas dimens&otilde;es. A    bi&oacute;psia desta les&atilde;o mostrou uma citologia compat&iacute;vel com    adenocarcinoma do pulm&atilde;o, motivo porque inicia novo ciclo de quimioterapia    com vinorelbina e gencitabina. Aos quatro ciclos e por n&atilde;o se evidenciar    nenhuma resposta ao tratamento, foi realizada radioterapia da les&atilde;o esquerda.    Durante este per&iacute;odo (28 meses) mant&eacute;m-se assintom&aacute;tica,    mantendo a sua actividade di&aacute;ria habitual. De acordo com o momento do    diagn&oacute;stico as neoplasias do pulm&atilde;o podem ser consideradas s&iacute;ncronas    ou met&aacute;cronas. Estas &uacute;ltimas s&atilde;o mais frequentes, representando    cerca de 50-70% dos casos, sendo o padr&atilde;o histol&oacute;gico mais frequente    o adenocarcinoma.</p>     ]]></body>
<body><![CDATA[<p align="justify">No caso apresentado, a situa&ccedil;&atilde;o parecia ser uma    doen&ccedil;a disseminada, o que afastou a hip&oacute;tese de tumores s&iacute;ncronos.    Apesar de a doen&ccedil;a se apresentar num est&aacute;dio avan&ccedil;ado aquando    do diagn&oacute;stico e do mau progn&oacute;stico associado, a evolu&ccedil;&atilde;o    dos dois tipos de tumor n&atilde;o pareceu comprometer a actividade di&aacute;ria    da doente.</p>      <p><i>Palavras-chave</i>: Tumor primitivo do pulm&atilde;o, tumores s&iacute;ncronos    do pulm&atilde;o, tumores met&aacute;cronos do pulm&atilde;o.</p>      <p>&nbsp;</p>      <p align="center"><b>Abstract</b></p>     <p align="justify">The authors describe the case of a 50 year old woman, smoker,    healthy until September 2003 when she presented persistent dry cough, fatigue    and weight loss. Chest x-ray showed two lung masses, one in the superior right    lobe and the other in the lingula lobe of the left lung.</p>     <p align="justify">The patient underwent TFNA (transthoracic fine needle aspiration)    and the cytological result was compatible with small cell lung cancer. Staging    procedures identified hepatic lesions, probably secondary. Presence of hepatic    metastasis and contralateral lung lesions defined the stage of the disease as    disseminate. Chemotherapy with carboplatin and etoposide was started. Six months    later the right lesion had decreased but the left lesion had increased. TFNA    of this lesion revealed adenocarcinoma. A new treatment was started with vinorelbine    and gemcitabine. After four cycles of chemotherapy without any response patient    underwent radiotherapy of the left lesion. After 28 months of follow up the    patient was asymptomatic and able to manage her normal daily routine. Multiple    lung cancers can be considered as synchronous or metachronous, depending on    the time of diagnosis. Metachronous lesions are the most frequent (50-70% of    all cases) and adeno- carcinoma the more frequent histological pattern. In this    case the disease was at a disseminate stage, which did not suggest a synchronous    lung tumour.</p>     <p align="justify">While the disease was at an advanced stage with poor prognosis    at diagnosis, the evolution of the two different lung tumours did not seem to    compromise patient&#8217;s daily routine.</p>      <p><i>Key-words</i>: Primitive lung tumor, synchronous tumor, metachronous lung    tumour.</p>      <p>&nbsp;</p>      <p>Texto completo disponível apenas em PDF.</p>     ]]></body>
<body><![CDATA[<p>Full text only available in PDF format.</p>      <p>&nbsp;</p>      <p align="center"><b>Bibliography</b></p>     <!-- ref --><p>1. Antakali T, Schaefer RF, Rutherford JE, et al. Second primary lung cancers.    <i>Ann Thoracic Surgery 1995</i>; 59:863.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000026&pid=S0873-2159200700020000900001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>2. Martini N, Melamed MR. Multiple primary lung cancers. <i>J Thoracic Cardiovascular    Surgery, 1975</i>, 70:606.</p>     <p>3. M van Rens M, Zanen P, Rivi&egrave;re A, Elbers H, Switen H, Bosch JM. Survival    in synchronous versus single lung cancer. Upstanding better reflects prognosis.<i>    Chest 2000</i>; 118: 952-958.</p>     <p>4. Tsunezuka Y, Matsumoto I, Tamura M et al. The results of therapy for bilateral    multiple lung cancers: 30 years of experience in a single center. <i>Eur J    Surg Oncology 2004</i>; 30:781.</p>     <p>5. Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy    for multiple primary lung cancers. <i>Chest 1997</i>; 112:693.</p>     <p>6. Martini N, Melamed MR, Multiple primary lung cancers. <i>J Thoracic Cardiovascular    Surg 1975</i>; 70.606.</p>      <p>&nbsp;</p>      ]]></body>
<body><![CDATA[<p><sup><a href="#top1">1</a><a name="1"></a></sup> Interna Complementar de Pneumologia</p>     <p><sup><a href="#top2">2</a><a name="2"></a></sup> Assistente Hospitalar Graduado    de Pneumologia,</p>     <p><sup><a href="#top3">3</a><a name="3"></a></sup> Professor Agregado da Faculdade    de Medicina da Universidade do Porto</p>      <p>Servi&ccedil;o de Pneumologia, Hospital de S&atilde;o Jo&atilde;o &#8211; Porto    (Portugal)</p>     <p>Director: J. Agostinho Marques</p>     <p>Faculdade de Medicina da Universidade do Porto</p>      <p><b>Correspondence address to:</b></p>     <p>Carla Damas</p>     <p>Travessa Fernando Namora, 48 - 5º Esq.</p>     <p>4425 Pedrouços - Maia </p>     ]]></body>
<body><![CDATA[<p>Portugal</p>      <p>&nbsp;</p>      <p>Recebido para publicação/received for publication: 05.12.22</p>     <p>Aceite para publicação/accepted for publication: 07.01.02</p>       ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antakali]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Schaefer]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Rutherford]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Second primary lung cancers.]]></article-title>
<source><![CDATA[Ann Thoracic Surgery]]></source>
<year>1995</year>
<volume>59</volume>
<page-range>863</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
